These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32334861)

  • 1. [A rare cause of impaired general condition: Muscular and cardiac toxicity of antimalarials].
    Lenfant T; Dion J; Maisonobe T; Costedoat-Chalumeau N
    Rev Med Interne; 2020 May; 41(5):335-338. PubMed ID: 32334861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial myopathy in a systemic lupus erythematosus patient with quadriparesis and seizures: a case-based review.
    Jafri K; Zahed H; Wysham KD; Patterson S; Nolan AL; Bucknor MD; Chaganti RK
    Clin Rheumatol; 2017 Jun; 36(6):1437-1444. PubMed ID: 28236156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyopathy related to antimalarial therapy with illustrative case report.
    Costedoat-Chalumeau N; Hulot JS; Amoura Z; Delcourt A; Maisonobe T; Dorent R; Bonnet N; Sablé R; Lechat P; Wechsler B; Piette JC
    Cardiology; 2007; 107(2):73-80. PubMed ID: 16804295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI.
    Hanneman K; Alberdi HV; Karur GR; Tselios K; Harvey PJ; Gladman DD; Akhtari S; Osuntokun T; Wald RM; Thavendiranathan P; Butany J; Urowitz MB
    JACC Cardiovasc Imaging; 2020 Mar; 13(3):879-881. PubMed ID: 31734202
    [No Abstract]   [Full Text] [Related]  

  • 5. 42-year-old man with discoid lupus and progressive weakness.
    Stevens MA; Yeaney GA; Lacomis D
    Brain Pathol; 2009 Jan; 19(1):153-6. PubMed ID: 19076781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients.
    Casado E; Gratacós J; Tolosa C; Martínez JM; Ojanguren I; Ariza A; Real J; Sanjuán A; Larrosa M
    Ann Rheum Dis; 2006 Mar; 65(3):385-90. PubMed ID: 16096334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proximal myopathy and fulminant heart failure in a 57 year-old female patient with lupus erythematosus].
    Wille F; Birkmeier S; Tiemann K; Lewalter T; Klingel K; Rabe C; Sick P
    Internist (Berl); 2020 Aug; 61(8):854-859. PubMed ID: 32504300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
    Azimian M; Gultekin SH; Hata JL; Atkinson JB; Ely KA; Fuchs HA; Mobley BC
    J Clin Rheumatol; 2012 Oct; 18(7):363-6. PubMed ID: 23047537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine neuromyotoxicity. Clinical and pathologic perspective.
    Estes ML; Ewing-Wilson D; Chou SM; Mitsumoto H; Hanson M; Shirey E; Ratliff NB
    Am J Med; 1987 Mar; 82(3):447-55. PubMed ID: 3826099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amphiphilic cationic drug myopathy, drug-induced lysosomal storage lipidosis].
    Kumamoto T
    Ryoikibetsu Shokogun Shirizu; 2001; (36):263-6. PubMed ID: 11596386
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxychloroquine-induced toxic myopathy causing respiratory failure.
    Siddiqui AK; Huberfeld SI; Weidenheim KM; Einberg KR; Efferen LS
    Chest; 2007 Feb; 131(2):588-90. PubMed ID: 17296665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hydroxychloroquine myopathy.
    Abdel-Hamid H; Oddis CV; Lacomis D
    Muscle Nerve; 2008 Sep; 38(3):1206-10. PubMed ID: 18720511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus.
    Tselios K; Gladman DD; Su J; Urowitz MB
    Lupus; 2016 Apr; 25(5):532-5. PubMed ID: 26585070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
    Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM
    J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early cardiotoxicity of Hydroxychloroquine].
    Zerbib Y; Guillaumont MP; Touati G; Duhaut P; Schmidt J
    Rev Med Interne; 2016 Mar; 37(3):209-11. PubMed ID: 26320366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restrictive Cardiomyopathy Associated With Long-Term Use of Hydroxychloroquine for Systemic Lupus Erythematosus.
    Sabato LA; Mendes LA; Cox ZL
    J Pharm Pract; 2017 Oct; 30(5):571-575. PubMed ID: 27353145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myopathy complicating lupus pregnancy.
    Priori R; Gattamelata A; d'Amati G; Giordano C; Piccioni MG; Valesini G; Framarino-dei-Malatesta M
    J Clin Rheumatol; 2013 Apr; 19(3):132-3. PubMed ID: 23519179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.
    Chatre C; Roubille F; Vernhet H; Jorgensen C; Pers YM
    Drug Saf; 2018 Oct; 41(10):919-931. PubMed ID: 29858838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eye toxicity of antimalarial agents].
    Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
    An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of myopathy in patients treated with antimalarials. A report of three cases and a review of the literature.
    Avina-Zubieta JA; Johnson ES; Suarez-Almazor ME; Russell AS
    Br J Rheumatol; 1995 Feb; 34(2):166-70. PubMed ID: 7704464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.